These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 9636441)
1. Analysis of B cell subsets responsible for the production of anti-donor antibodies in hamster-to-rat xenorejection. Wakiyama S; Cramer DV; Wu GD; Swensson J; Gochi E; Mendez R Transplant Proc; 1998 Jun; 30(4):1085-6. PubMed ID: 9636441 [No Abstract] [Full Text] [Related]
2. Genetic characteristics of anti-donor immunoglobulin G antibodies in the hamster-to-rat model of xenotransplantation. Gochi E; Cramer DV; Wu GD; Kearns M; Swensson J; Wakiyama S; Mendez R Transplant Proc; 1998 Jun; 30(4):1089-90. PubMed ID: 9636443 [No Abstract] [Full Text] [Related]
3. Genetic evidence that the antibody response to xenografts is directed at a restricted number of target antigens. Wu GD; Cramer DV; Shirwan H; Borie D; Chapman FA Transplant Proc; 1997; 29(1-2):954. PubMed ID: 9123604 [No Abstract] [Full Text] [Related]
4. The rejection of hamster xenografts by rats is mediated by a restricted repertoire of Ig heavy chain variable genes. Cramer DV; Wu GD; Borie DC; Shirwan H; Makowka L Transplant Proc; 1996 Apr; 28(2):569-70. PubMed ID: 8623276 [No Abstract] [Full Text] [Related]
6. Maturation of xenoantibody gene expression during the humoral immune response of rats to hamster xenografts. Wu GD; Gochi E; Jin YS; Swensson J; Starnes VA; Cramer DV Xenotransplantation; 2001 Nov; 8(4):291-302. PubMed ID: 11737855 [TBL] [Abstract][Full Text] [Related]
7. Suppression of T-independent IgM xenoantibody formation by leflunomide during xenografting of hamster hearts in rats. Lin Y; Vandeputte M; Waer M Transplantation; 1998 Feb; 65(3):332-9. PubMed ID: 9484748 [TBL] [Abstract][Full Text] [Related]
8. Genetic control of the humoral responses to xenografts. III. Identification of the immunoglobulin V(H) genes responsible for encoding rat immunoglobin G xenoantibodies to hamster heart grafts. Gochi E; Wu GD; Wakiyama S; Kearns-Jonker M; Swensson J; Cramer DV Transplantation; 1999 Jul; 68(1):15-24. PubMed ID: 10428261 [TBL] [Abstract][Full Text] [Related]
9. Mechanism of leflunomide-induced prevention of xenoantibody formation and xenograft rejection in the hamster to rat heart transplantation model. Lin Y; Sobis H; Vandeputte M; Waer M Transplant Proc; 1995 Feb; 27(1):305-6. PubMed ID: 7879012 [No Abstract] [Full Text] [Related]
10. Anti-CD4 monoclonal antibody treatment combined with total lymphoid irradiation and cyclosporin A in hamster-to-rat cardiac transplantation. Analysis of lymphocyte subsets and anti-donor xenoantibodies. Steinbrüchel DA; Madsen HH; Lillevang S; Nielsen B; Kemp E Transpl Immunol; 1993; 1(3):209-16. PubMed ID: 7915954 [TBL] [Abstract][Full Text] [Related]
11. The antigenicity of serum proteins and their role in xenograft rejection. Celli S; Kelly RH; Rao AS; Pan F; Sun H; Nalesnik M; Wakizaka Y; Fung JJ; Starzl TE; Valdivia LA Transplant Proc; 1996 Apr; 28(2):669-70. PubMed ID: 8623335 [No Abstract] [Full Text] [Related]
12. A comparison of lymphocytic subsets participating in concordant cardiac xenograft and acute cardiac allograft rejection. Cramer DV; Wu GD; Chapman FA; Wang HK; Cajulis E; Makowka L Transplant Proc; 1992 Apr; 24(2):533-4. PubMed ID: 1566419 [No Abstract] [Full Text] [Related]
13. Accommodated xenografts survive in the presence of anti-donor antibodies and complement that precipitate rejection of naive xenografts. Lin Y; Soares MP; Sato K; Takigami K; Csizmadia E; Smith N; Bach FH J Immunol; 1999 Sep; 163(5):2850-7. PubMed ID: 10453031 [TBL] [Abstract][Full Text] [Related]
14. Natural killer cells, antibody-dependent cellular cytotoxicity, and complement synthesis by the xenograft itself play a role in xenograft rejection. Lin Y; Sobis H; Vandeputte M; Waer M Transplant Proc; 1995 Feb; 27(1):286-7. PubMed ID: 7879005 [No Abstract] [Full Text] [Related]
15. Pretreatment of recipients (nude rat) with donor antigens leads to prolonged survival of hamster heart xenografts. Tsugita M; Rao AS; Sun H; Wakizaka Y; Madariaga J; Pan F; Demetris AJ; Fung JJ; Starzl TE; Valdivia LA Transplant Proc; 1996 Apr; 28(2):696-7. PubMed ID: 8623351 [No Abstract] [Full Text] [Related]
17. Complement-fixing elicited antibodies are a major component in the pathogenesis of xenograft rejection. Miyatake T; Sato K; Takigami K; Koyamada N; Hancock WW; Bazin H; Latinne D; Bach FH; Soares MP J Immunol; 1998 Apr; 160(8):4114-23. PubMed ID: 9558123 [TBL] [Abstract][Full Text] [Related]
18. Rejection and accommodation in the hamster-to-rat heart transplantation model. Bouwman E; Scheringa M; Nio D; IJzermans JN; Marquet RL Transplant Proc; 1994 Apr; 26(2):992-3. PubMed ID: 8171723 [No Abstract] [Full Text] [Related]
19. Tetrahydropyranyladriamycin with FK 506 combination therapy for hamster-to-rat-concordant xenotransplantation. Namii Y; Yasutomi M; Hayashi S; Ito M; Ohtsuka S; Uchida K; Yokoyama I; Takagi H Transplant Proc; 1996 Apr; 28(2):709-10. PubMed ID: 8623358 [No Abstract] [Full Text] [Related]
20. Detection of rat antibodies against hamster heart: reactivity of natural antibodies in a concordant model. Lillevang ST; Steinbrüchel DA; Kemp E Transplant Proc; 1994 Apr; 26(2):989-91. PubMed ID: 8171722 [No Abstract] [Full Text] [Related] [Next] [New Search]